RTSL Gross Margin

As of 2025-05-21, the Gross Margin of Rapid Therapeutic Science Laboratories Inc (RTSL) is 62.3%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

RTSL Gross Margin - Historical Value

Date	Value
2022-12-31	62.3%
2021-12-31	62.3%
2020-12-31	85.2%
2020-03-31	21.7%
2019-03-31	-
2018-03-31	-
2017-03-31	-
2016-03-31	-
2015-03-31	-
2014-03-31	-

RTSL Gross Margin - Peers Comparison

Ticker	Name	Value
AJIA	Ajia Innogroup Holdings Ltd	38.4%
ARMC	Un Monde International Ltd	9.4%
BIEL	BioElectronics Corp	49.4%
CATV	4Cable TV International Inc	27.2%
CNTR.CN	Centr Brands Corp	-56.2%
ECRP	Chee Corp	90%
GFP.V	GreenFirst Forest Products Inc	-
GLUC	Glucose Health Inc	43%
HOLL.CN	Hollister Biosciences Inc	1023.6%
HP.CN	Hello Pal International Inc	10.5%
HULK.V	Pontus Protein Ltd	7775.2%
INNO.CN	Innocan Pharma Corp	89%
ISH.CN	Inner Spirit Holdings Ltd	47.2%
NEOV	NeoVolta Inc	19.3%
NVG.CN	Nass Valley Gateway Ltd	-588.3%
ODII	Odyssey Semiconductor Technologies Inc	29.8%
SIGY	Sigyn Therapeutics Inc	75.2%
SLBG	Slinger Bag Inc	28.9%
UNSS	Universal Solar Technology Inc	-210.1%
VDKB	Vodka Brands Corp	23.4%
VIHD	VISION HYDROGEN Corp	26.7%
VPH.CN	Valeo Pharma Inc	29.2%
ZAIR.CN	Zinc8 Energy Solutions Inc	7775.2%